Format
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 5

1.

The side effects of hormonal therapy at the patients with prostate cancer.

Ziółkowska E, Zarzycka M, Wiśniewski T, Zyromska A.

Contemp Oncol (Pozn). 2012;16(6):491-7. doi: 10.5114/wo.2012.32478. Epub 2013 Jan 4.

2.

Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer.

Shahinian VB, Kuo YF.

J Gen Intern Med. 2013 Nov;28(11):1440-6. doi: 10.1007/s11606-013-2477-2. Epub 2013 May 14.

3.

Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy.

Morgans AK, Smith MR, O'Malley AJ, Keating NL.

Cancer. 2013 Feb 15;119(4):863-70. doi: 10.1002/cncr.27830. Epub 2012 Oct 12.

4.

The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer.

Al-Shamsi HO, Lau AN, Malik K, Alamri A, Ioannidis G, Corbett T, Adachi JD, Papaioannou A.

J Oncol. 2012;2012:958596. doi: 10.1155/2012/958596. Epub 2012 Apr 30.

5.

Nutraceuticals in Prostate Disease: The Urologist's Role.

Curtis Nickel J, Shoskes D, Roehrborn CG, Moyad M.

Rev Urol. 2008 Summer;10(3):192-206.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk